Modules
Crestview Medical Associates, LLC
Customer 8532
- Account Classification
- Physician-Office Laboratory
- Classification Confidence
- High
- Sites
- HQ | f3992507b48bc2c26541a1beca953b22c21f8c69e5c05badd198a85811e2dfa0
- Assigned Reps
- Marcus Feldman
- Website
- —
- Active Opportunity Count
- 14
- Published Count
- 8
- Revenue Base
- 16280.18
- Known GPBase
- 4998.38
- Analyzer Platforms
- Beckman Access / DxI | Olympus / Beckman AU
- Product Groups
- Beckman Access | Olympus | Services Group
- Recommended Contact
- Xander Ellery
- Backup Contact
- Kyle Lindqvist | Gather Supplies Purchasing | kyle.lindqvist@crestviewmedicalassociatesllc.com | (337) 718-3735
- Last Meaningful Activity
- 2026-04-06
- Customer Memory
- Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement N/A. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified item fact: storage requirement N/A. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Olympus / Beckman AU. Verified item fact: storage requirement Fridge. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-4feefa73d6e35106488c98516e06b68aa887c69f0ba338055c87c91aa36e839f | Customer 8532 | Candidate CAND-c6b8e296a5e6ef08f090bcccf1fafc014426389222d79258b067a9bb908d6223 | Customer 8532 | Item 4880 | Candidate CAND-058f961d1e83ede6d53ba2e6d62df0c87bb0b706b5da9b4f1c5cb2293f7e7f73 | Customer 8532 | Quote 28031 | Item 15789 | Candidate CAND-f96daf5b3e9fd007b68049376aa7f4d38e758bef3171ffc330967da5f8bc51cc | Customer 8532 | Order 47191 | Item 12162 | Candidate CAND-f7b065a8c985b3d7b23780d27047a1948a89acfa8dbbf83f4ddabeecffcd703d | Customer 8532 | Order 46485 | Item 12163 | Candidate CAND-e05c6a1ebaef86d34e4ef9f23b5b016d26e53d055a9c72c820fa81886a587961 | Customer 8532 | Order 47191 | Item 11343 | Candidate CAND-5ace9090263c69b507346a8163ca045051e232db61bec21c4042466f5b965c6d | Customer 8532 | Order 47191 | Item 12330 | Candidate CAND-6b6fff50105c88907e627e26ff1702b705ca7feadedd6541fa2619c0aa94e612 | Customer 8532 | Order 45667 | Item 11341
Opportunities (20)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4feefa73d6e35106488c98516e06b68aa887c69f0ba338055c87c91aa36e839f | OPP-ff5f08acf06cd52d664a1eae724e29c9f46ea62cfa0237efc8defb9d2f4c4404 | SER-fb78acf6069dc14e2af951d7a7bcb5f67f8077e2de1b2f7938ab6c643f7adddf | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 8 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4771.09; 235 days beyond expected account order date. | 4264.62 | 8529.24 | 12793.86 | 2159.63 | 4319.26 | 6478.89 | 92.53 | High | False | True | — | CALL | Candidate CAND-4feefa73d6e35106488c98516e06b68aa887c69f0ba338055c87c91aa36e839f | Customer 8532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f96daf5b3e9fd007b68049376aa7f4d38e758bef3171ffc330967da5f8bc51cc | OPP-16f12f854f4d6b5e984a7bd7a857756489994fe3034aac455f9af905ecfa5d45 | SER-48b4bb43b49d4bd0baeefd8decd64ac930a7b811d60916c97c745d44a6852140 | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6196 | OSR6196 Olympus LDL-C (LDL Cholesterol) Reagent, 4x30 mL & 4x10 mL | — | 47191 | 4 completed purchases over 685 days; median interval 163.0 days; expected reorder 2026-02-10; High Risk by 181 days. | 1119.17 | 1492.23 | 1865.29 | 169.55 | 226.07 | 282.58 | 65.39 | Medium | False | False | — | CALL | Candidate CAND-f96daf5b3e9fd007b68049376aa7f4d38e758bef3171ffc330967da5f8bc51cc | Customer 8532 | Order 47191 | Item 12162 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f7b065a8c985b3d7b23780d27047a1948a89acfa8dbbf83f4ddabeecffcd703d | OPP-b6c8a087ececbfd9001dc4113160d1b2c4ec26b02c5f0b1382a85cf287dae86e | SER-dc0ac686860279d8014515195f6a7c68ca72948d8790324a15e778fc59e08c5f | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6195 | OSR6195 Olympus HDL-C (HDL Cholesterol) Reagent, 4 x 30 mL & 4 x 10 mL | — | 46485 | 4 completed purchases over 525 days; median interval 170.0 days; expected reorder 2025-12-05; High Risk by 248 days. | 573.75 | 765 | 956.25 | 82.31 | 109.74 | 137.18 | 62.76 | Medium | False | False | — | CALL | Candidate CAND-f7b065a8c985b3d7b23780d27047a1948a89acfa8dbbf83f4ddabeecffcd703d | Customer 8532 | Order 46485 | Item 12163 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ecdab1ae518f4d9fa393035eeb3e9c607b8e0b6dd72ffea5a972b02de9857f0b | OPP-0e5390fd4ba46a7699274677d4e93f42fa7ab7abc7e80df9de763a2f686110a2 | SER-5c2923f6d83022690f4a75f26825362d1999c1c1202d1afa153f579efebec207 | Needs Validation | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6106 | OSR6106 Olympus AMY (Amylase) Reagent, 4 x 40 mL | — | 44794 | 3 completed purchases over 491 days; median interval 245.5 days; expected reorder 2025-11-06; High Risk by 277 days. | 271.35 | 361.8 | 452.25 | 164.85 | 219.8 | 274.75 | 61.27 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-ecdab1ae518f4d9fa393035eeb3e9c607b8e0b6dd72ffea5a972b02de9857f0b | Customer 8532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e05c6a1ebaef86d34e4ef9f23b5b016d26e53d055a9c72c820fa81886a587961 | OPP-73f7f18bc4015f96eee542641aa7a9e2af4ed8a7b02d979607b3045d8dc559b4 | SER-045a4ae89f8fa64766d2e4ad1dea00a589d5d5a9af78a3118960f95bd96b921f | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6107 | OSR6107 Olympus ALT Reagent (4x980 tests) | — | 47191 | 4 completed purchases over 631 days; median interval 203.0 days; expected reorder 2026-02-15; High Risk by 176 days. | 151.88 | 202.5 | 253.13 | 92.63 | 123.5 | 154.38 | 59.26 | Medium | False | False | — | CALL | Candidate CAND-e05c6a1ebaef86d34e4ef9f23b5b016d26e53d055a9c72c820fa81886a587961 | Customer 8532 | Order 47191 | Item 11343 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5ace9090263c69b507346a8163ca045051e232db61bec21c4042466f5b965c6d | OPP-45642638b4427e94fe1401ebfc22142b3167908a033e33a86577c1fbd2255259 | SER-ff5e7b9176284a92d21e65220a4e185b2bb999b7fa57f62d34cdca018f0249a2 | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | ODC0024 | ODC0024 Olympus LDL Cholesterol Calibrator, 3 x 1 mL | — | 47191 | 5 completed purchases over 631 days; median interval 187.5 days; expected reorder 2025-12-27; High Risk by 226 days. | 226.01 | 301.35 | 376.69 | 23.22 | 30.96 | 38.7 | 59.21 | Medium | False | False | — | CALL | Candidate CAND-5ace9090263c69b507346a8163ca045051e232db61bec21c4042466f5b965c6d | Customer 8532 | Order 47191 | Item 12330 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6b6fff50105c88907e627e26ff1702b705ca7feadedd6541fa2619c0aa94e612 | OPP-493cc3f9a667359e8dcc2493ddb01b302297fb1c50eb094d283f5a2193ff8552 | SER-10e6016b30b7f29bd4c6a705dd3e629b85a7c458251171e42236d673e9eec1c4 | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6132 | OSR6132 Olympus TP Reagent (4x750 tests) | — | 45667 | 4 completed purchases over 421 days; median interval 169.0 days; expected reorder 2025-09-22; High Risk by 322 days. | 123.75 | 165 | 206.25 | 87 | 116 | 145 | 58 | Medium | False | False | — | CALL | Candidate CAND-6b6fff50105c88907e627e26ff1702b705ca7feadedd6541fa2619c0aa94e612 | Customer 8532 | Order 45667 | Item 11341 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a59dbd640cb519bcafed0d15082ce8500dbc69df4fec00944775dfae28f1e99e | OPP-9d16ea50022c5e1e27038befe7a3a2d886c4f90d7c69fef5a1a90b2d553445ff | SER-12d2e08a09637efafd1a418ba82377228a0af50317a303b8fa36aa978f52191d | Needs Validation | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR61205 | OSR61205 UIBC (Unsaturated Iron Binding Capacity) Reagent, 4 x 240 Tests | — | 46293 | 4 completed purchases over 580 days; median interval 211.0 days; expected reorder 2025-12-19; High Risk by 234 days. | 112.5 | 150 | 187.5 | 27.75 | 37 | 46.25 | 56.55 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-a59dbd640cb519bcafed0d15082ce8500dbc69df4fec00944775dfae28f1e99e | Customer 8532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f8344f88c67c585ea71d1c86ebfe94b9b18c869e40a78f2900e9a6549e71bc7f | OPP-a543a09d0d2de2cce97603e7e00a28f6b57e6c4729646f5b14bc564ad808b4bb | SER-ca8890ba5bab53d146dc94f31b5d49841800efed45afbc8f9adaf369df38f215 | Needs Validation | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | 472137 | 472137 Beckman Synchron and AU Systems Hemolyzing Reagent, 1000 Tests | — | 46485 | 3 completed purchases over 384 days; median interval 192.0 days; expected reorder 2025-12-24; High Risk by 229 days. | 136.8 | 182.4 | 228 | 39.15 | 52.2 | 65.25 | 56.38 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-f8344f88c67c585ea71d1c86ebfe94b9b18c869e40a78f2900e9a6549e71bc7f | Customer 8532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-275608835bf8d22234bf07e0ce3a953ebe04289a25a0f38c2f3a4ddd47a93e32 | OPP-bfb531d05faef7ede7bfaacd871e14a8c7c0ccc8403636a781ade0547c356220 | SER-2da1596e40613535cfbe7ef3aab66117f41837350c9d25e06b3b54525f20f049 | Needs Validation | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6178 | Olympus OSR6178 CREATININE Reagent (4x990 tests) | — | 47191 | 3 completed purchases over 422 days; median interval 211.0 days; expected reorder 2026-02-19; High Risk by 172 days. | 193.75 | 258.33 | 322.92 | 144 | 192 | 240 | 55.87 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-275608835bf8d22234bf07e0ce3a953ebe04289a25a0f38c2f3a4ddd47a93e32 | Customer 8532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-30a800db9d90d13b700b9126b8b4bb58ecbb32f838ab236d5409d242973f7b8c | OPP-7a833195b1b9acc34dc6a90aa6352cc5b33c33fabc5179aa9f53064d2b9c43e6 | SER-d83a62dbeb59be264d928d5a2a9931dc98fe2907cde235b83277aadf2fc79372 | Needs Validation | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6109 | OSR6109 Olympus AST Reagent (4x980 tests) | — | 48185 | 4 completed purchases over 693 days; median interval 203.0 days; expected reorder 2026-05-01; Overdue by 101 days. | 151.88 | 202.5 | 253.13 | 86.63 | 115.5 | 144.38 | 55.83 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-30a800db9d90d13b700b9126b8b4bb58ecbb32f838ab236d5409d242973f7b8c | Customer 8532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cd96ee49ec5ce7e2a01f239848c951bc0374bbc54777cebe841e8a7f6b25f24f | OPP-6d7d970e2cf2db066f9c713975a23524d2cdb438b7b7e6b1a7674d589cd8b077 | SER-edcee4c82fa86296638be767fac468b1f5477fae2e849b2a67c9e6867c4954c6 | Needs Validation | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6121 | OSR6121 Olympus Gluc Reagent (4x610 tests) | — | 48968 | 4 completed purchases over 585 days; median interval 197.0 days; expected reorder 2026-05-21; Overdue by 81 days. | 120 | 160 | 200 | 85.5 | 114 | 142.5 | 52.42 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-cd96ee49ec5ce7e2a01f239848c951bc0374bbc54777cebe841e8a7f6b25f24f | Customer 8532 |
| Quote Leakage | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-058f961d1e83ede6d53ba2e6d62df0c87bb0b706b5da9b4f1c5cb2293f7e7f73 | OPP-2028bbb67e2bf174908a42ee0053bf6d61aea59cd97f9092cf483e50e63f930f | SER-755cc711d86949c22c6627daf7dd254e305a5df17b992abbcaa458b928e93e20 | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | — | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | — | Services Group | Beckman-AU480 Proactive Plan | Plan includes unlimited technical support, one preventative maintenance visit per year, inclusive of parts, labor and travel related to the standard preventative maintenance service; unlimited repair calls per year; and a 24 hour onsite response time. Refer to plan service agreement for limitations, terms and conditions. | 28031 | — | Stale Open Quote on quote 28031; quote age 293 days; last modified 292 days ago; quoted value $22500.00; converted line value $0.00; unconverted line value $22500.00. | 2250 | 4500 | 6750 | — | — | — | 69.23 | Medium | False | True | — | RESEND_QUOTE | Candidate CAND-058f961d1e83ede6d53ba2e6d62df0c87bb0b706b5da9b4f1c5cb2293f7e7f73 | Customer 8532 | Quote 28031 | Item 15789 |
| Cross-Sell | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c6b8e296a5e6ef08f090bcccf1fafc014426389222d79258b067a9bb908d6223 | OPP-556635373f31b5f98f9db13601873e4ec87690db0ab7b4f0ee5d18ed8e90e34b | SER-85a3d2b2ea3ab98de09c5cd1e18f465fd91424c8efb3892958a37deb8c6201ae | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | 81901 | 81901 Beckman Access Cuvette Reaction Vessels | — | — | Verified by Description for Beckman Access / DxI; item purchased by 16 of 40 comparable active sites (40.0%); peer median annual revenue $324.86. | 162.43 | 324.86 | 487.29 | 36.43 | 72.85 | 109.28 | 59.65 | High | False | False | — | CONFIRM_ANALYZER | Candidate CAND-c6b8e296a5e6ef08f090bcccf1fafc014426389222d79258b067a9bb908d6223 | Customer 8532 | Item 4880 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ecdab1ae518f4d9fa393035eeb3e9c607b8e0b6dd72ffea5a972b02de9857f0b | OPP-0e5390fd4ba46a7699274677d4e93f42fa7ab7abc7e80df9de763a2f686110a2 | SER-5c2923f6d83022690f4a75f26825362d1999c1c1202d1afa153f579efebec207 | — | **** | — | — | Crestview Medical Associates, LLC | 8532 | HQ | — | CA | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 3 completed purchases over 491 days; median interval 245.5 days; expected reorder 2025-11-06; High Risk by 277 days. | — | 361.8 | — | — | 219.8 | — | 61.27 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-ecdab1ae518f4d9fa393035eeb3e9c607b8e0b6dd72ffea5a972b02de9857f0b | Customer 8532 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a59dbd640cb519bcafed0d15082ce8500dbc69df4fec00944775dfae28f1e99e | OPP-9d16ea50022c5e1e27038befe7a3a2d886c4f90d7c69fef5a1a90b2d553445ff | SER-12d2e08a09637efafd1a418ba82377228a0af50317a303b8fa36aa978f52191d | — | **** | — | — | Crestview Medical Associates, LLC | 8532 | HQ | — | CA | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 4 completed purchases over 580 days; median interval 211.0 days; expected reorder 2025-12-19; High Risk by 234 days. | — | 150 | — | — | 37 | — | 56.55 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-a59dbd640cb519bcafed0d15082ce8500dbc69df4fec00944775dfae28f1e99e | Customer 8532 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f8344f88c67c585ea71d1c86ebfe94b9b18c869e40a78f2900e9a6549e71bc7f | OPP-a543a09d0d2de2cce97603e7e00a28f6b57e6c4729646f5b14bc564ad808b4bb | SER-ca8890ba5bab53d146dc94f31b5d49841800efed45afbc8f9adaf369df38f215 | — | **** | — | — | Crestview Medical Associates, LLC | 8532 | HQ | — | CA | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 3 completed purchases over 384 days; median interval 192.0 days; expected reorder 2025-12-24; High Risk by 229 days. | — | 182.4 | — | — | 52.2 | — | 56.38 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-f8344f88c67c585ea71d1c86ebfe94b9b18c869e40a78f2900e9a6549e71bc7f | Customer 8532 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-275608835bf8d22234bf07e0ce3a953ebe04289a25a0f38c2f3a4ddd47a93e32 | OPP-bfb531d05faef7ede7bfaacd871e14a8c7c0ccc8403636a781ade0547c356220 | SER-2da1596e40613535cfbe7ef3aab66117f41837350c9d25e06b3b54525f20f049 | — | **** | — | — | Crestview Medical Associates, LLC | 8532 | HQ | — | CA | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 3 completed purchases over 422 days; median interval 211.0 days; expected reorder 2026-02-19; High Risk by 172 days. | — | 258.33 | — | — | 192 | — | 55.87 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-275608835bf8d22234bf07e0ce3a953ebe04289a25a0f38c2f3a4ddd47a93e32 | Customer 8532 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-30a800db9d90d13b700b9126b8b4bb58ecbb32f838ab236d5409d242973f7b8c | OPP-7a833195b1b9acc34dc6a90aa6352cc5b33c33fabc5179aa9f53064d2b9c43e6 | SER-d83a62dbeb59be264d928d5a2a9931dc98fe2907cde235b83277aadf2fc79372 | — | **** | — | — | Crestview Medical Associates, LLC | 8532 | HQ | — | CA | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 4 completed purchases over 693 days; median interval 203.0 days; expected reorder 2026-05-01; Overdue by 101 days. | — | 202.5 | — | — | 115.5 | — | 55.83 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-30a800db9d90d13b700b9126b8b4bb58ecbb32f838ab236d5409d242973f7b8c | Customer 8532 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cd96ee49ec5ce7e2a01f239848c951bc0374bbc54777cebe841e8a7f6b25f24f | OPP-6d7d970e2cf2db066f9c713975a23524d2cdb438b7b7e6b1a7674d589cd8b077 | SER-edcee4c82fa86296638be767fac468b1f5477fae2e849b2a67c9e6867c4954c6 | — | **** | — | — | Crestview Medical Associates, LLC | 8532 | HQ | — | CA | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 4 completed purchases over 585 days; median interval 197.0 days; expected reorder 2026-05-21; Overdue by 81 days. | — | 160 | — | — | 114 | — | 52.42 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-cd96ee49ec5ce7e2a01f239848c951bc0374bbc54777cebe841e8a7f6b25f24f | Customer 8532 |